The United States Food and Drug Administration (USFDA) have inspected Torrent Pharmaceuticals’ Levittown, Pennsylvania, USA manufacturing facility between December 6, 2021 and December 15, 2021. At the end of the inspection No Form 483 was issued. It is a positive development for the company and is a reflection of its commitment to consistency in quality and compliance with regulatory standards.
Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.
